Projects per year
Personal profile
Biography
John joined Alfred Health in October 2014 as the Scientific Director of the Biostatistics Consulting Platform in the Faculty of Medicine, Nursing and Health Sciences Monash University and The Alfred Hospital. From February 2022 he assumed the role of Senior Expert Biostatistician in the Department of Clinical Haematology at The Alfred. He obtained his PhD in Statistics, with a Minor in Genetics, from North Carolina State University (Raleigh). His experience, gained at Peter Mac, Novartis AG and Deakin University, lies mainly in the design and analysis of oncology clinical trials (all phases) but his early-career experience was gained in the design and analysis of experiments in the food and agricultural sciences.
Research interests
Web of Science Researcher ID: https://publons.com/researcher/2658815/john-reynolds/
Google Scholar: https://scholar.google.com.au/citations?hl=en&user=_pHSeSkAAAAJ
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GLAM study - Genomic Liquid biopsy Analysis for Multiple myeloma
Spencer, A. (Primary Chief Investigator (PCI)), Mithraprabhu, S. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Wellard, C. (Chief Investigator (CI)), Bingham, N. (Chief Investigator (CI)), Wong, D. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)), Wright, T. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)) & McCaughan, G. (Chief Investigator (CI))
1/08/24 → 31/07/28
Project: Research
-
Defining the circulating genome of high-risk plasma cell disorders to improve risk stratification and clinical management
Mithraprabhu, S. (Primary Chief Investigator (PCI)), Khong, T. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Murray, D. (Chief Investigator (CI)), Shah, J. (Chief Investigator (CI)), Wellard, C. (Chief Investigator (CI)), Spencer, A. (Associate Investigator (AI)), Ross, J. (Associate Investigator (AI)), Perkins, A. (Associate Investigator (AI)), Marks, A. (Associate Investigator (AI)), Beer, H. (Associate Investigator (AI)) & Henderson, M. (Associate Investigator (AI))
1/04/24 → 31/12/26
Project: Research
-
A Centralized Platform for Functional High Risk Multiple Myeloma – THE ZEPFHR MM Trial (AMaRC 22-03)
Spencer, A. (Primary Chief Investigator (PCI)), Ho, P. J. (Chief Investigator (CI)), Quach, H. (Chief Investigator (CI)), Hill, G. R. (Chief Investigator (CI)), Reddel, R. (Chief Investigator (CI)), Bingham, N. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Mithraprabhu, S. (Chief Investigator (CI)), Chng, W. J. (Chief Investigator (CI)), Erber, W. (Chief Investigator (CI)), Lim, S.-L. (Chief Investigator (CI)), Bryant, C. (Chief Investigator (CI)), Harrison, S. J. (Associate Investigator (AI)), Le, K. (Associate Investigator (AI)), Henderson, M. (Associate Investigator (AI)), Beer, H. (Associate Investigator (AI)), Vandyke, K. (Associate Investigator (AI)), Kemp, R. (Associate Investigator (AI)), Marks, A. (Associate Investigator (AI)) & Taylor, K. M. D. (Chief Investigator (CI))
1/03/24 → 28/02/29
Project: Research
-
RATIONAL: Generating evidence to improve use of immunoglobulin replacement to reduce infections in blood cancers: the RATIONAL Platform Trial
McQuilten, Z. (Primary Chief Investigator (PCI)), Wood, E. (Chief Investigator (CI)), Morrissey, O. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Opat, S. (Chief Investigator (CI)), Hawkes, E. (Chief Investigator (CI)), Stanworth, S. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Roberts, J. A. (Chief Investigator (CI)), Mulligan, S. (Chief Investigator (CI)), Crispin, P. (Chief Investigator (CI)), Weinkove, R. (Chief Investigator (CI)), Peterson, D. L. (Chief Investigator (CI)) & Ryan, L. (Associate Investigator (AI))
1/04/22 → 31/03/27
Project: Research
-
More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial
Spencer, A. (Primary Chief Investigator (PCI)), Rutherford, C. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)), McQuilten, Z. (Chief Investigator (CI)), Moore, E. (Chief Investigator (CI)), King, T. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Harrison, S. J. (Chief Investigator (CI)) & Irving, A. (Chief Investigator (CI))
Department of Health, Disability and Ageing (Australia)
1/02/22 → 31/01/27
Project: Research
-
A biomarker risk assessment tool predicts infection-related mortality after allogeneic stem cell transplantation
Tan, J. L. C. (Leading Author), Khong, T., Kim, Y. J., Reynolds, J., Barmanray, R. D., Gardiner, B., Morrissey, C. O., Mithraprabhu, S. & Spencer, A. (Leading Author), 24 Mar 2026, In: Blood Advances. 10, 6, p. 2054-2064 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Measurable residual disease intervention in AML: a new therapeutic horizon
Wei, A. H. (Leading Author), Iland, H. J. (Leading Author), DiNardo, C. D. (Leading Author) & Reynolds, J. (Leading Author), 1 Jan 2026, In: Blood. 147, 1, p. 13-23 11 p.Research output: Contribution to journal › Article › Research › peer-review
7 Link opens in a new tab Citations (Scopus) -
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia
Yeung, D. T. (Leading Author), Grigg, A. P. (Leading Author), Reynolds, J. (Leading Author), Branford, S., Mazumdar, D., Cunningham, I., Shortt, J., Rowlings, P., Harrup, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C. K., Schwarer, A., Jackson, K., Viiala, N., Weinkove, R., Yong, A. S. M., Gazdar, S. G. & White, D. & 3 others, , Feb 2026, In: British Journal of Haematology. 208, 2, p. 599-607 9 p.Research output: Contribution to journal › Article › Research › peer-review
-
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL
Iland, H. J., Reynolds, J., Boddy, A. V., Schultz, H. B., Khoo, L., Fleming, S., Lane, S. W., Weber, N., Gasiorowski, R., Armytage, T., Harrup, R., Watson, A. M., Tan, P., Filshie, R., Kwok, F., Stevenson, W., Yuen, S., Ng, A. P., Rowley, L. & Marlton, P. & 2 others, , 25 Mar 2025, In: Blood Advances. 9, 6, p. 1476-1484 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Link opens in a new tab Citations (Scopus) -
Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma
Zhao, J., Khong, T., Gorniak, M., Khaled, A., McDonald, Z., Reynolds, J., Mithraprabhu, S., Bingham, N., Lim, S., Wong, D., Johnston, A., Motorna, O., Murphy, N., Quach, H., Yang, L. & Spencer, A., Mar 2025, In: Haematologica. 110, 3, p. 764-767 4 p.Research output: Contribution to journal › Letter › Research › peer-review
Open Access4 Link opens in a new tab Citations (Scopus)
Activities
-
American Society of Hematology, Clinical Research Training Institute 2026
Reynolds, J. (Invited speaker)
12 Apr 2026 → 15 Apr 2026Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
American Society of Hematology, Clinical Research Training Institute 2025
Reynolds, J. (Invited speaker)
18 Feb 2025 → 21 Feb 2025Activity: Participating in or organising an event types › Contribution to conference
-
American Society of Hematology, Clinical Research Training Institute 2024
Reynolds, J. (Invited speaker)
13 Feb 2024 → 14 Feb 2024Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
CML Opinion Leader Training
Reynolds, J. (Invited speaker)
7 Sept 2023 → 8 Sept 2023Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
American Society of Hematology, Clinical Research Training Institute 2023
Reynolds, J. (Invited speaker)
7 Mar 2023 → 9 Mar 2023Activity: Participating in or organising an event types › Contribution to workshop, seminar, course